Annual Net Income
$71.41 M
-$11.67 M-14.05%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual net profit is currently $71.41 million, with the most recent change of -$11.67 million (-14.05%) on 31 December 2023. During the last 3 years, it has fallen by -$3.57 million (-4.77%). CPRX annual net income is now -14.05% below its all-time high of $83.08 million, reached on 31 December 2022.CPRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$43.88 M
+$3.09 M+7.57%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly net profit is currently $43.88 million, with the most recent change of +$3.09 million (+7.57%) on 30 September 2024. Over the past year, it has increased by +$74.65 million (+242.65%). CPRX quarterly net income is now at all-time high.CPRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$142.80 M
+$74.65 M+109.54%
30 September 2024
Summary:
Catalyst Pharmaceuticals TTM net profit is currently $142.80 million, with the most recent change of +$74.65 million (+109.54%) on 30 September 2024. Over the past year, it has increased by +$80.76 million (+130.18%). CPRX TTM net income is now at all-time high.CPRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.1% | +242.7% | +130.2% |
| 3 y3 years | -4.8% | +324.9% | +243.2% |
| 5 y5 years | +310.0% | +222.0% | +1411.7% |
CPRX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -14.1% | +80.9% | at high | +242.7% | at high | +261.7% |
| 5 y | 5 years | -14.1% | +310.0% | at high | +242.7% | at high | +1411.7% |
| alltime | all time | -14.1% | +310.0% | at high | +242.7% | at high | +520.0% |
Catalyst Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $43.88 M(+7.6%) | $142.80 M(+109.5%) |
| June 2024 | - | $40.79 M(+75.3%) | $68.15 M(+4.7%) |
| Mar 2024 | - | $23.27 M(-33.2%) | $65.12 M(-8.8%) |
| Dec 2023 | $71.41 M(-14.0%) | $34.84 M(-213.3%) | $71.41 M(+15.1%) |
| Sept 2023 | - | -$30.76 M(-181.5%) | $62.04 M(-46.3%) |
| June 2023 | - | $37.76 M(+27.7%) | $115.55 M(+16.2%) |
| Mar 2023 | - | $29.57 M(+16.1%) | $99.41 M(+19.7%) |
| Dec 2022 | $83.08 M(+110.4%) | $25.47 M(+12.0%) | $83.08 M(+24.2%) |
| Sept 2022 | - | $22.75 M(+5.2%) | $66.92 M(+22.8%) |
| June 2022 | - | $21.62 M(+63.3%) | $54.50 M(+20.9%) |
| Mar 2022 | - | $13.24 M(+42.2%) | $45.06 M(+14.1%) |
| Dec 2021 | $39.48 M(-47.3%) | $9.31 M(-9.9%) | $39.48 M(-5.1%) |
| Sept 2021 | - | $10.33 M(-15.2%) | $41.61 M(-44.2%) |
| June 2021 | - | $12.18 M(+59.0%) | $74.62 M(+3.3%) |
| Mar 2021 | - | $7.66 M(-33.0%) | $72.22 M(-3.7%) |
| Dec 2020 | $74.98 M(+135.2%) | $11.44 M(-73.6%) | $74.98 M(+4.9%) |
| Sept 2020 | - | $43.34 M(+343.1%) | $71.48 M(+71.1%) |
| June 2020 | - | $9.78 M(-6.2%) | $41.77 M(-2.7%) |
| Mar 2020 | - | $10.43 M(+31.5%) | $42.95 M(+34.7%) |
| Dec 2019 | $31.88 M(-193.7%) | $7.93 M(-41.8%) | $31.88 M(+237.4%) |
| Sept 2019 | - | $13.63 M(+24.4%) | $9.45 M(-178.6%) |
| June 2019 | - | $10.96 M(-1800.5%) | -$12.02 M(-58.5%) |
| Mar 2019 | - | -$644.50 K(-95.6%) | -$28.95 M(-14.9%) |
| Dec 2018 | -$34.00 M(+84.7%) | -$14.50 M(+85.0%) | -$34.00 M(+36.6%) |
| Sept 2018 | - | -$7.84 M(+31.4%) | -$24.89 M(+17.2%) |
| June 2018 | - | -$5.97 M(+4.7%) | -$21.23 M(+10.9%) |
| Mar 2018 | - | -$5.70 M(+5.8%) | -$19.15 M(+4.0%) |
| Dec 2017 | -$18.41 M(+1.9%) | -$5.39 M(+29.0%) | -$18.41 M(+7.1%) |
| Sept 2017 | - | -$4.18 M(+7.7%) | -$17.19 M(+1.3%) |
| June 2017 | - | -$3.88 M(-21.9%) | -$16.96 M(-3.9%) |
| Mar 2017 | - | -$4.97 M(+19.3%) | -$17.65 M(-2.3%) |
| Dec 2016 | -$18.07 M(-10.7%) | -$4.16 M(+5.3%) | -$18.07 M(-8.4%) |
| Sept 2016 | - | -$3.95 M(-13.5%) | -$19.72 M(-2.4%) |
| June 2016 | - | -$4.57 M(-15.2%) | -$20.22 M(+0.1%) |
| Mar 2016 | - | -$5.39 M(-7.4%) | -$20.21 M(-0.1%) |
| Dec 2015 | -$20.23 M(+30.5%) | -$5.82 M(+30.7%) | -$20.23 M(+13.0%) |
| Sept 2015 | - | -$4.45 M(-2.4%) | -$17.91 M(-3.0%) |
| June 2015 | - | -$4.56 M(-15.7%) | -$18.47 M(+8.0%) |
| Mar 2015 | - | -$5.41 M(+55.0%) | -$17.11 M(+10.3%) |
| Dec 2014 | -$15.51 M | -$3.49 M(-30.3%) | -$15.51 M(+16.0%) |
| Sept 2014 | - | -$5.01 M(+56.7%) | -$13.37 M(-6.3%) |
| June 2014 | - | -$3.20 M(-16.1%) | -$14.28 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$3.81 M(+181.3%) | -$14.22 M(+17.0%) |
| Dec 2013 | -$12.15 M(+198.2%) | -$1.35 M(-77.1%) | -$12.15 M(+11.8%) |
| Sept 2013 | - | -$5.91 M(+88.1%) | -$10.88 M(+43.4%) |
| June 2013 | - | -$3.14 M(+80.2%) | -$7.59 M(+60.3%) |
| Mar 2013 | - | -$1.74 M(+2177.2%) | -$4.73 M(+16.1%) |
| Dec 2012 | -$4.08 M(-36.2%) | -$76.60 K(-97.1%) | -$4.08 M(-35.8%) |
| Sept 2012 | - | -$2.62 M(+806.8%) | -$6.35 M(+30.7%) |
| June 2012 | - | -$289.10 K(-73.5%) | -$4.86 M(-18.5%) |
| Mar 2012 | - | -$1.09 M(-53.7%) | -$5.96 M(-6.7%) |
| Dec 2011 | -$6.39 M(+59.5%) | -$2.35 M(+108.5%) | -$6.39 M(+34.0%) |
| Sept 2011 | - | -$1.13 M(-19.1%) | -$4.77 M(+4.9%) |
| June 2011 | - | -$1.39 M(-8.1%) | -$4.54 M(+1.5%) |
| Mar 2011 | - | -$1.52 M(+108.2%) | -$4.48 M(+11.8%) |
| Dec 2010 | -$4.01 M(-44.7%) | -$728.80 K(-19.4%) | -$4.01 M(-9.8%) |
| Sept 2010 | - | -$904.00 K(-32.0%) | -$4.44 M(-7.9%) |
| June 2010 | - | -$1.33 M(+27.1%) | -$4.82 M(-8.2%) |
| Mar 2010 | - | -$1.04 M(-10.1%) | -$5.26 M(-27.4%) |
| Dec 2009 | -$7.24 M(-31.5%) | -$1.16 M(-9.7%) | -$7.24 M(-26.3%) |
| Sept 2009 | - | -$1.29 M(-27.0%) | -$9.83 M(-13.8%) |
| June 2009 | - | -$1.76 M(-41.9%) | -$11.40 M(-5.1%) |
| Mar 2009 | - | -$3.03 M(-19.1%) | -$12.01 M(+13.7%) |
| Dec 2008 | -$10.56 M(+155.2%) | -$3.75 M(+31.2%) | -$10.56 M(+36.1%) |
| Sept 2008 | - | -$2.86 M(+20.1%) | -$7.76 M(+37.6%) |
| June 2008 | - | -$2.38 M(+50.1%) | -$5.64 M(+26.2%) |
| Mar 2008 | - | -$1.58 M(+67.6%) | -$4.47 M(+8.0%) |
| Dec 2007 | -$4.14 M(+51.7%) | -$944.90 K(+28.7%) | -$4.14 M(+5.2%) |
| Sept 2007 | - | -$734.30 K(-39.2%) | -$3.94 M(-13.0%) |
| June 2007 | - | -$1.21 M(-3.5%) | -$4.52 M(+23.3%) |
| Mar 2007 | - | -$1.25 M(+68.9%) | -$3.67 M(+33.4%) |
| Dec 2006 | -$2.73 M(+51.2%) | -$741.20 K(-43.9%) | -$2.75 M(-17.4%) |
| Sept 2006 | - | -$1.32 M(+273.3%) | -$3.33 M(+48.0%) |
| June 2006 | - | -$354.00 K(+6.2%) | -$2.25 M(-12.0%) |
| Mar 2006 | - | -$333.40 K(-74.8%) | -$2.56 M(-11.3%) |
| Dec 2005 | -$1.81 M(+234.5%) | -$1.32 M(+446.4%) | -$2.89 M(+69.9%) |
| Sept 2005 | - | -$241.90 K(-63.4%) | -$1.70 M(+6.7%) |
| June 2005 | - | -$660.80 K(0.0%) | -$1.59 M(+49.3%) |
| Mar 2005 | - | -$660.80 K(+389.5%) | -$1.07 M(+97.4%) |
| Dec 2004 | -$539.80 K(+25.9%) | -$135.00 K(0.0%) | -$540.00 K(+33.3%) |
| Sept 2004 | - | -$135.00 K(0.0%) | -$405.00 K(+50.0%) |
| June 2004 | - | -$135.00 K(0.0%) | -$270.00 K(+100.0%) |
| Mar 2004 | - | -$135.00 K | -$135.00 K |
| Dec 2003 | -$428.60 K(+67.5%) | - | - |
| Dec 2002 | -$255.90 K | - | - |
FAQ
- What is Catalyst Pharmaceuticals annual net profit?
- What is the all time high annual net income for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual net income year-on-year change?
- What is Catalyst Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly net income year-on-year change?
- What is Catalyst Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM net income year-on-year change?
What is Catalyst Pharmaceuticals annual net profit?
The current annual net income of CPRX is $71.41 M
What is the all time high annual net income for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual net profit is $83.08 M
What is Catalyst Pharmaceuticals annual net income year-on-year change?
Over the past year, CPRX annual net profit has changed by -$11.67 M (-14.05%)
What is Catalyst Pharmaceuticals quarterly net profit?
The current quarterly net income of CPRX is $43.88 M
What is the all time high quarterly net income for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly net profit is $43.88 M
What is Catalyst Pharmaceuticals quarterly net income year-on-year change?
Over the past year, CPRX quarterly net profit has changed by +$74.65 M (+242.65%)
What is Catalyst Pharmaceuticals TTM net profit?
The current TTM net income of CPRX is $142.80 M
What is the all time high TTM net income for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM net profit is $142.80 M
What is Catalyst Pharmaceuticals TTM net income year-on-year change?
Over the past year, CPRX TTM net profit has changed by +$80.76 M (+130.18%)